1. Home
  2. |Professionals
  3. |Michelle L. Chipetine

Michelle L. Chipetine

Counsel
Counsel
bWNoaXBldGluZUBjcm93ZWxsLmNvbQ==
VCardLinkedIn
VCardLinkedIn

Areas of Focus

Overview

Michelle Chipetine is a counsel in Crowell & Moring’s New York office and a member of the firm’s Health Care and Intellectual Property groups.

Michelle’s practice focuses on patent and health care litigation and counseling health care entities and not-for-profit corporations on a wide range of regulatory, transactional, and corporate matters. Michelle works with all types of health care entities, including hospitals, pharmacies, laboratories, and health plans, seeking to comply with federal and state laws and regulations, including those related to fraud and abuse, telemedicine, licensing, and reimbursement.

Before joining Crowell & Moring, Michelle graduated cum laude from Fordham University School of Law, where she was actively involved with Fordham’s Neuroscience and Law Center. Michelle also studied neuroscience at Vassar College, where she graduated cum laude.

Career & Education

|

    • Vassar College, B.A., cum laude, neuroscience, 2015
    • Fordham University School of Law, J.D., cum laude, 2018
    • Vassar College, B.A., cum laude, neuroscience, 2015
    • Fordham University School of Law, J.D., cum laude, 2018

    • New York
    • New York

Michelle's Insights

Client Alert | 5 min read | 03.28.25

HHS Announces “Dramatic Restructuring”

On March 27, 2025, HHS announced a “dramatic restructuring” of its various agencies and offices in accordance with President Trump's Executive Order, “Implementing the President’s ‘Department of Government Efficiency’ Workforce Optimization Initiative.” HHS also published a Fact Sheet....

View All Insights

Representative Matters

  • Secured a significant victory (a preliminary injunction against patent infringement through trial) on behalf of Lonza Walkersville, Inc. against Israel-based Adva Biotechnology Ltd. in a case involving point-of-care cell-therapy technology.

Michelle's Insights

Client Alert | 5 min read | 03.28.25

HHS Announces “Dramatic Restructuring”

On March 27, 2025, HHS announced a “dramatic restructuring” of its various agencies and offices in accordance with President Trump's Executive Order, “Implementing the President’s ‘Department of Government Efficiency’ Workforce Optimization Initiative.” HHS also published a Fact Sheet....

View All Insights

Insights

Client Alert | 5 min read | 03.28.25

HHS Announces “Dramatic Restructuring”

Client Alert | 2 min read | 02.21.25

First Circuit Clarifies “Resulting From” Standard Under Anti-Kickback Statute, Reshaping False Claims Act Litigation

Blog Post | 01.30.25

FDA Clarifies Enforcement Policy Around Communications of Scientific Information on Unapproved Uses of Drugs and Medical Devices

Blog Post | 11.05.24

Stringent Requirements for Pleading Fraud Under Rule 9(b).
|

View All Insights

Practices

Michelle's Insights

Client Alert | 5 min read | 03.28.25

HHS Announces “Dramatic Restructuring”

On March 27, 2025, HHS announced a “dramatic restructuring” of its various agencies and offices in accordance with President Trump's Executive Order, “Implementing the President’s ‘Department of Government Efficiency’ Workforce Optimization Initiative.” HHS also published a Fact Sheet....

View All Insights